Clinical Trial Update: The Guardcontrol Trial: Study to Assess if Type 1 Diabetics Can Improve Using the Real-time Values of Guardian RT [NA]

View source ↗

Summary

A completed clinical trial evaluating real-time Guardian RT data in type 1 diabetes management; results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetes Mellitus

Drugs mentioned

• Guardian RT

Snippet

Sponsor: Medtronic MiniMed, Inc. | Conditions: Diabetes Mellitus | NA | Status: COMPLETED | Results posted: 2019-04-01